Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein – A position paper from the IFCC Committee on bone metabolism

•Brief presentation of the metabolism of vitamin D.•Detailed presentation of preanalytical variables affecting the measurement of vitamin D metabolites.•Detailed presentation and recommendations on the analytical measurement and clinical usefulness of vitamin D metabolites.•Current status and future...

Full description

Saved in:
Bibliographic Details
Published in:Clinica chimica acta Vol. 517; pp. 171 - 197
Main Authors: Makris, Konstantinos, Bhattoa, Harjit P, Cavalier, Etienne, Phinney, Karen, Sempos, Christopher T., Ulmer, Candice Z., Vasikaran, Samuel D., Vesper, Hubert, Heijboer, Annemieke C.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-06-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Brief presentation of the metabolism of vitamin D.•Detailed presentation of preanalytical variables affecting the measurement of vitamin D metabolites.•Detailed presentation and recommendations on the analytical measurement and clinical usefulness of vitamin D metabolites.•Current status and future goals for the standardization of analytical methods. Vitamin D, an important hormone with a central role in calcium and phosphate homeostasis, is required for bone and muscle development as well as preservation of musculoskeletal function. The most abundant vitamin D metabolite is 25-hydroxyvitamin D [25(OH)D], which is currently considered the best marker to evaluate overall vitamin D status. 25(OH)D is therefore the most commonly measured metabolite in clinical practice. However, several other metabolites, although not broadly measured, are useful in certain clinical situations. Vitamin D and all its metabolites are circulating in blood bound to vitamin D binding protein, (VDBP). This highly polymorphic protein is not only the major transport protein which, along with albumin, binds over 99% of the circulating vitamin D metabolites, but also participates in the transport of the 25(OH)D into the cell via a megalin/cubilin complex. The accurate measurement of 25(OH)D has proved a difficult task. Although a reference method and standardization program are available for 25(OH)D, the other vitamin D metabolites still lack this. Interpretation of results, creation of clinical supplementation, and generation of therapeutic guidelines require not only accurate measurements of vitamin D metabolites, but also the accurate measurements of several other “molecules” related with bone metabolism. IFCC understood this priority and a committee has been established with the task to support and continue the standardization processes of vitamin D metabolites along with other bone-related biomarkers. In this review, we present the position of this IFCC Committee on Bone Metabolism on the latest developments concerning the measurement and standardization of vitamin D metabolites and its binding protein, as well as clinical indications for their measurement and interpretation of the results.
Bibliography:CRediT authorship contribution statement
Konstantinos Makris: Conceptualization, Writing - original draft. Harjit P Bhattoa: Writing - review & editing. Etienne Cavalier: Supervision, Writing - review & editing. Karen Phinney: Writing - review & editing. Christopher T. Sempos: Writing - review & editing. Candice Z. Ulmer: Writing - review & editing. Samuel D. Vasikaran: Writing - review & editing. Hubert Vesper: Writing - review & editing. Annemieke C. Heijboer: Conceptualization, Writing - original draft.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2021.03.002